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even several days, and has low sensitivity, which 
allows to detect microbial growth only in 15% to 
30% of the culture.2
To improve the effectiveness of identifying 
the etiological agent in blood, attempts have 
been undertaken to detect lipopolysaccharide 
for Gram ‑negative bacteria or mannan and ga‑
lactomannan for fungi, using serological meth‑
ods. Other promising diagnostic tools are signif‑
icantly faster and more precise molecular meth‑
ods based on polymerase chain reaction (PCR). 
Molecular biology techniques are independent 
of prior antibiotic treatment and do not require 
bacterial or fungal growth in a culture medium.3,4
Serological or molecular diagnosis based on 
the PCR methods is costly and requires special‑
ized diagnostic laboratories. Screening methods 
would be extremely valuable as they could quickly 
reveal the presence of bacteria in the direct smear. 
Such methods include Gram staining and fluo‑
rescent in situ hybridization (FISH). Therefore, 
the objective of this study was to compare cul‑
turing with the modified method for blood sam‑
ple preparation for Gram staining and FISH in 
the direct smear from blood.
Patients and methods A total of 53 blood sam‑
ples from adult patients with suspected sepsis 
were analyzed on the basis of the clinical picture 
and laboratory tests results. The blood samples 
were taken from patients of the Department of 
Anesthesiology and Intensive Care in the John 
Paul II Hospital in Kraków, Poland, in the years 
from 2012 to 2013. The research was approved 
Introduction According to the Sepsis Definitions 
Task Force of the Society of Critical Care Med‑
icine and European Society of Intensive Care 
Medicine, sepsis is currently defined as “life‑
‑threatening organ dysfunction caused by a dys‑
regulated host response to infection,”1 and its di‑
agnostic criteria rely on sepsis ‑related organ fail‑
ure assessment scores—SOFA or qSOFA. Sep‑
sis is diagnosed when SOFA score is 2 points 
or higher, if infection is present or suspect‑
ed, or if there are 2 or more symptoms accord‑
ing to the qSOFA score (disorders of conscious‑
ness, systolic blood pressure ≤100 mmHg, re‑
spiratory rate ≥22 breaths/min). Additionally, 
systemic inflammatory response syndrome was 
left out of the definition of sepsis and the term 
“sepsis” replaced “severe sepsis.”
A proinflammatory response developing in 
an uncontrolled way in the body can lead to multi‑
ple organ dysfunction syndrome, including death. 
Therefore, discovering the source of infection ear‑
ly and determining the etiologic agent are crucial 
for the treatment optimization, employing effec‑
tive targeted antibiotic therapy, and consequently, 
improving the prognosis for patients with sepsis.
Detection of bacteria in blood might prove dif‑
ficult owing to their relatively small number and 
periodic seeding into the bloodstream, and also 
as a result of the antibiotic therapy applied, which 
reduces the chance of culturing them. Currently, 
the gold standard in microbiological diagnostics 
of blood is its culture in automated systems (eg, 
BACTEC [BectonDickinson]). The disadvantage 
is that this method is time ‑consuming, taking 
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Preparation and gram staining of direct blood smears 
Direct smears were prepared from blood samples 
ready for determination using FISH by conduct‑
ing hemolysis of erythrocytes with a solution of 
ammonium chloride, and the leukocyte precip‑
itate obtained was used to prepare microscope 
slides.5 Subsequently, standard Gram staining was 
applied. The preparations were examined using 
the CX21 light microscope (Olympus).
Statistical methods For statistical analysis, the 
2 ‑tailed Fisher exact test was used (Gretl soft‑
ware ver. 1.9.4., Toruń, Poland).
Results In total, 53 blood samples were test‑
ed using the blood culture, Gram ‑stained direct 
smears, and FISH (FIGURE 1A–1D), and the follow‑
ing percentages of positive results were obtained: 
26.4% (n = 14); 43.4% (n = 23), and 50.9% (n = 27), 
respectively. Sensitivity and specificity for Gram 
staining and FISH compared to culture was 85.7% 
and 71.8% as well as 100% and 66.7%, respective‑
ly. Significant differences were found between 
the results obtained through blood culture and 
Gram staining (F = 0.00032; P <0.01) as well as 
culture and FISH (F = 0.00012; P <0.01). The time 
required to obtain test results using Gram stain‑
ing and FISH amounted to about 4 to 5 hours, 
while for the culture it was even 72 hours.
Discussion Despite the tremendous progress 
in the diagnosis and treatment of sepsis, blood 
by the Jagiellonian University Bioethics Commit‑
tee (KBET/94/B/2009). Blood was drawn from 
patients who met the existing clinical criteria 
for sepsis.
The blood culture was carried out in the John 
Paul II Hospital in the Department of Microbiol‑
ogy, using the BacT/ALERT® 3D apparatus (bio‑
Mérieux, Hazelwood, Missouri, United States). Si‑
multaneously, the blood samples were analyzed 
using FISH and Gram staining.
Fluorescent in situ hybridization in whole blood 
Blood samples were subjected to in situ hybrid‑
ization according to the method described by Go‑
siewski et al.5 In order to detect bacteria, the fol‑
lowing fluorophore ‑labeled probes (Genomed, 
Warsaw, Poland) were used: probe EUB338 to de‑
tect all species of bacteria cumulatively: (FITC ‑5’– 
GCT GCC TCC CGT AGG AGT– 3’‑FITC)6; probe 
STA—for the genus Staphylococcus: (CY3 ‑5’– TCC 
TCC ATA TCT CTG CGC 3’)7; and probe ENT183—
for Enterobacteriaceae (CY3 ‑5’‑ CTC TTT GGT CTT 
GCG ACG ‑3’).8
The preparations were analyzed using the BX51 
fluorescence microscope (Olympus, Ontario, 
Canada) equipped with an immersion objective 
100×, an ultravioloet lamp, and an F ‑View cam‑
era (Olympus). Image analysis was carried out 
using the AnalySIS software (Soft Imaging, On‑
tario, Canada).
FIGURE 1 Microscopic 
images (zoom, ×1000); 
A – fluorescent in situ 
hybridization (FISH) smear 
with STA and EUB338 
probes: visible 
Staphylococcus spp cells; 
B – Gram smear: visible 
Gram ‑positive cocci; C – 
FISH smear with ENT183 
and EUB338 probes: 
visible Enterobacteriaceae 
cells; D – Gram smear: 
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waiting for the results of standard laboratory 
tests. The applied Gram staining may also be con‑
sidered a rapid screening test on similar princi‑
ples as cerebrospinal fluid direct smear testing; 
however, it shows lower sensitivity and specific‑
ity than FISH.
Excluding the fluorescence microscope and 
thermocycler equipment, the cost of FISH and 
Gram ‑staining analysis is lower than that of the 
PCR amplification.
The search for alternatives to the gold standard 
of blood culture is still a pressing issue. The meth‑
ods that we propose could be used at least as com‑
plementary diagnostic tools before further prog‑
ress in the diagnosis, management, and care of 
patients with sepsis is made.13
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culture still remains the gold standard in every‑
day clinical practice. Undoubtedly, the merits of 
this test are its simplicity, low cost, and the pos‑
sibility of determining bacterial susceptibility to 
antibiotics. The downside of bacterial culture in 
blood is the time required to perform the test 
and low sensitivity. Bacteria can be cultured from 
blood only in about 15% to 30% of cases, and 
the result is obtained after 3 to 5 days, which 
may have serious consequences for the patient’s 
health or even life.5,9 Hence, studies are being 
conducted to find alternative diagnostic meth‑
ods, and they are mainly based on molecular bi‑
ology research.2,4 Recently, our team demonstrat‑
ed the presence of bacterial DNA in the blood of 
both healthy individuals and patients with sepsis. 
We noticed considerable taxonomic diversity be‑
tween the 2 groups. Among healthy individuals, 
anaerobic bacteria DNA dominated in the blood, 
and in the group with sepsis, aerobic and micro‑
aerophilic bacteria DNA was mainly present.10 
It brings us to a conclusion that the blood from 
each patient with symptoms of sepsis should be 
routinely tested for bacteremia.
In our study, we employed the FISH technique 
and Gram staining for direct smears of patients’ 
blood subjected to preliminary preparation. It 
is common knowledge that Gram‑stained direct 
smears do not constitute valuable diagnostic ma‑
terial because the image is obscured by eryth‑
rocytes. In literature, numerous reports can be 
found on the use of FISH for testing samples of 
fluids following blood culture.11,12
Owing to hemoglobin sample purification in ac‑
cordance with the methodology described by Go‑
siewski et al,5 in which a clear microscopic picture 
of good quality was obtained without background 
autofluorescence, the FISH method can be suc‑
cessfully applied today for whole blood, without 
prior culture. Analogous methods were used in 
the preparation of Gram smears, wherein eryth‑
rocytes were initially removed, and at the same 
time, the sample was concentrated.
High sensitivity of FISH testing (100%) and 
Gram staining (85.7%) was observed, but spec‑
ificity was 85.7% and 71.8%, respectively. This 
difference most probably stems from the fact 
that a blood culture reveals only living and pro‑
liferating bacteria, while FISH and Gram stain‑
ing can also confirm the presence of dead cells.12 
Blood culture has numerous limitations, includ‑
ing a small number of microbes in the blood and 
the use of antibiotics that inhibit the growth of 
bacteria. Furthermore, the strains cultured could 
have started through contamination. The short‑
coming of our study was that we did not moni‑
tor the time of blood collection for microbiolog‑
ical testing in relation to the applied antibiot‑
ic treatment.
The highest proportion of positive results was 
obtained using the FISH method. Therefore, it 
seems that this method, based on molecular bi‑
ology, may be successfully applied in laborato‑
ry diagnosis of sepsis as a screening tool while 
